hepatocellular jaundice

The conclusion and analysis of syndrome discipline are significant for the prevention and cure of Hepatocellular jaundice .

证候规律的总结和分析，对肝细胞性黄疸的防治有一定的指导意义。

The Clinical Study on Regularity of Syndrome and Relevant Factor of Hepatocellular Jaundice

肝细胞性黄疸证候特点及相关因素的理论探讨与临床研究

Effective observation of treating hepatocellular jaundice with Qingkailing

清开灵治疗肝细胞性黄疸疗效观察

Hepatocellular jaundice resulting from simvastatin

辛伐他汀致肝细胞性黄疸

Continuous transarterial infusion chemotherapy with Aidi combined with transhepatic arterial embolism in treatment of liver malignant tumor with hepatocellular jaundice

艾迪持续动脉灌注联合栓塞治疗伴有肝细胞黄疸的肝脏恶性肿瘤

These findings indicated that the rat is more suitable for reproducing the model of hepatocellular jaundice with CCl_4 than the rabbit .

本研究表明，用大鼠复制CCl4肝细胞性黄疸模型似比家兔更理想。

All of total , hepatocellular jaundice was seventy cases , caused by acute and chronic liver function failure and severe hepatitis . Obstructive jaundice was 6 cases , caused by tumor and lithiasis .

均为急慢性肝功能衰竭、重型肝炎造成的肝细胞性黄疸和肿瘤、结石等阻塞胆管而造成的梗阻性黄疸，其中肝细胞性黄疸70例，梗阻性黄疸6例。

The operation on hepatocellular carcinoma with obstructive jaundice as primary symptom

以阻塞性黄疸为首发症状的肝癌的手术治疗

Diagnostic and therapeutic ERCP on hepatocellular carcinoma with obstructive jaundice

肝细胞癌所致梗阻性黄疸的ERCP诊断与治疗